Assessing the role of immuno-proteasomes in a mouse model of familial ALS

[1]  A. Salminen,et al.  Pyrrolidine Dithiocarbamate Inhibits Induction of Immunoproteasome and Decreases Survival in a Rat Model of Amyotrophic Lateral Sclerosis , 2007, Molecular Pharmacology.

[2]  E. Kabashi,et al.  Failure of protein quality control in amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[3]  G. Kollias,et al.  Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.

[4]  M. Groettrup,et al.  An Altered T Cell Repertoire in MECL-1-Deficient Mice1 , 2006, The Journal of Immunology.

[5]  P. Hart,et al.  Proteasomal Degradation of Mutant Superoxide Dismutases Linked to Amyotrophic Lateral Sclerosis* , 2005, Journal of Biological Chemistry.

[6]  J. Elliott,et al.  Non-neuronal induction of immunoproteasome subunits in an ALS model: Possible mediation by cytokines , 2005, Experimental Neurology.

[7]  P. Cascio,et al.  Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome , 2005, Neurobiology of Disease.

[8]  J. Agar,et al.  Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis , 2004, Journal of neurochemistry.

[9]  A. Bruce-Keller,et al.  Loss of an individual proteasome subunit alters motor function but not cognitive function or ambulation in mice , 2004, Neuroscience Letters.

[10]  Isidro Ferrer,et al.  Neuronal Induction of the Immunoproteasome in Huntington's Disease , 2003, The Journal of Neuroscience.

[11]  G. Demartino,et al.  Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes , 2003, Journal of neurochemistry.

[12]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[13]  A. Goldberg,et al.  The Caspase-like Sites of Proteasomes, Their Substrate Specificity, New Inhibitors and Substrates, and Allosteric Interactions with the Trypsin-like Sites* , 2003, Journal of Biological Chemistry.

[14]  R. Takahashi,et al.  Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.

[15]  U. Krishnan,et al.  Disease Progression in a Transgenic Model of Familial Amyotrophic Lateral Sclerosis Is Dependent on Both Neuronal and Non-Neuronal Zinc Binding Proteins , 2002, The Journal of Neuroscience.

[16]  Hermann-Georg Holzhütter,et al.  Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formation. , 2002, Journal of molecular biology.

[17]  D. Borchelt,et al.  High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation , 2002, Neurobiology of Disease.

[18]  D. Price,et al.  Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues , 2001, Neurobiology of Disease.

[19]  M. Gurney,et al.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Snider,et al.  Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration , 2000, The Journal of Neuroscience.

[21]  C. Slaughter,et al.  The Proteasome, a Novel Protease Regulated by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.

[22]  D. Borchelt,et al.  ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.

[23]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[24]  W. Hung,et al.  Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.

[25]  P. Kloetzel,et al.  20S proteasome from LMP7 knock out mice reveals altered proteolytic activities and cleavage site preferences , 1996, FEBS letters.

[26]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[27]  J. Morrison,et al.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[29]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[30]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[31]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.